stoxline Quote Chart Rank Option Currency Glossary
  
Myomo, Inc. (MYO)
2.72  -0.1 (-3.55%)    04-17 16:00
Open: 2.85
High: 2.97
Volume: 151,619
  
Pre. Close: 2.82
Low: 2.72
Market Cap: 77(M)
Technical analysis
2024-04-17 4:48:23 PM
Short term     
Mid term     
Targets 6-month :  4.02 1-year :  4.7
Resists First :  3.44 Second :  4.03
Pivot price 3.04
Supports First :  2.51 Second :  2.08
MAs MA(5) :  2.86 MA(20) :  3.16
MA(100) :  3.69 MA(250) :  2.02
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  17.8 D(3) :  13.6
RSI RSI(14): 36.5
52-week High :  5.57 Low :  0.37
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MYO ] has closed above bottom band by 8.1%. Bollinger Bands are 44.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.97 - 2.99 2.99 - 3
Low: 2.68 - 2.7 2.7 - 2.71
Close: 2.69 - 2.72 2.72 - 2.74
Company Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Headline News

Thu, 28 Mar 2024
Myomo Inc Enhances Board with Expert Heather Getz - TipRanks.com - TipRanks

Mon, 18 Mar 2024
Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) - GuruFocus.com

Sun, 10 Mar 2024
Myomo, Inc.: In Motion To Accelerating Revenue Growth (NYSE:MYO) - Seeking Alpha

Thu, 07 Mar 2024
Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript - Seeking Alpha

Thu, 07 Mar 2024
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire

Thu, 07 Mar 2024
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 27 (M)
Shares Float 15 (M)
Held by Insiders 13.8 (%)
Held by Institutions 47.9 (%)
Shares Short 236 (K)
Shares Short P.Month 298 (K)
Stock Financials
EPS -0.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.41
Profit Margin -42.5 %
Operating Margin -39.9 %
Return on Assets (ttm) -34.4 %
Return on Equity (ttm) -83.4 %
Qtrly Rev. Growth 28 %
Gross Profit (p.s.) 0.38
Sales Per Share 0.69
EBITDA (p.s.) -0.3
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -5.56
PEG Ratio 35.1
Price to Book value 6.47
Price to Sales 3.89
Price to Cash Flow -11.49
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android